Chemours (CC) Misses Q4 EPS by 21c

Chemours (NYSE: CC) reported Q4 EPS of $0.08, $0.21 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.24 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• RBC Capital Downgrades Dow Inc. (DOW) to Sector Perform
• Kepler Cheuvreux Downgrades Berkeley Group Holdings Plc. (BKG:LN) (BKGFF) to Reduce